HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multivariate analysis of prognostic determinants after surgery for renal cell carcinoma at Himeji National Hospital.

Abstract
A clinico-pathological study was performed retrospectively on 62 patients who underwent surgery for renal cell carcinoma between January 1992 and October 1998 at Himeji National Hospital to clarify the prognostic determinants for survival. The median follow-up period was 32 months and the cause-specific survival rates at 1, 3 and 5 years were 86.7, 81.3, 81.3%, respectively. Of the 62 patients, 11 (17.7%) patients died of renal cell carcinoma and 2 (3.2%) patients died of unrelated causes. Of the variables related to survival, presenting symptoms, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), alkaline phosphatase (ALP), tumor size, pathological tumor grade, infiltration pattern, pathological tumor stage, N classification and M classification were significant risk factors for survival by univariate analysis. However, ALP, N classification and M classification were significant for survival as determined by the step-wise procedure and M classification was the most significant factor according to Cox's proportional hazard model analysis.
AuthorsT Inoue, T Hashimura, H Iwamura, T Takahashi, T Segawa, Y Kakehi, T Nakano, M Hiura, A Kanematsu, Y Katsura, Y Katsura
JournalHinyokika kiyo. Acta urologica Japonica (Hinyokika Kiyo) Vol. 46 Issue 4 Pg. 229-34 (Apr 2000) ISSN: 0018-1994 [Print] Japan
PMID10845152 (Publication Type: Journal Article)
Topics
  • Adult
  • Aged
  • Carcinoma, Renal Cell (classification, pathology, surgery)
  • Female
  • Follow-Up Studies
  • Hospitals, Public
  • Humans
  • Japan
  • Kidney Neoplasms (classification, pathology, surgery)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Staging
  • Nephrectomy
  • Prognosis
  • Risk Factors
  • Survival Rate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: